Euphorbia schimperiana
Euphorbia schimperiana · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Euphorbia schimperiana is a plant species recognized for its significant therapeutic potential in traditional medicine. Scientific investigations have focused on its antimicrobial activities to combat various pathogenic threats. Specifically, researchers have utilized 80% methanol extracts derived from the plant's root to study its medicinal properties. These extracts have shown promise in addressing respiratory conditions such as asthma, cough, and sore throat. Furthermore, the plant is being explored for its efficacy in managing more severe ailments like tuberculosis.
- Synonyms
- Tithymalus Schimperianus
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Pacific
- Plant Parts
- Root
Classification
Synonyms
Euphorbia schimperiana is a botanical subject that is frequently identified by its alternative scientific name, Tithymalus schimperianus. This taxonomic synonym reflects the complex historical shifts within plant classification systems. While researchers may use different terminology, both names refer to the exact same species. Understanding these linguistic variations is essential for accurate identification in both field studies and herbarium records. Consequently, recognizing this relationship ensures clarity when navigating diverse scientific literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Euphorbia schimperiana is a distinctive species that belongs to the vast kingdom Plantae. Within this biological kingdom, it is classified under the class Equisetopsida. Its evolutionary lineage places it firmly within the order Malpighiales. Furthermore, this plant is a member of the diverse family Euphorbiaceae. Ultimately, it is defined by its specific placement within the genus Euphorbia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Euphorbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euphorbia schimperiana is a notable plant species with a widespread distribution across the African continent. Its presence is particularly concentrated within the East Tropical Africa region, where it can be found in Kenya, Tanzania, and Uganda. Beyond these eastern territories, the species also extends into Northeast Tropical Africa. Specifically, its range encompasses the landscapes of Djibouti and Eritrea. This diverse geographical spread highlights the plant's ability to thrive across various environments within these distinct African regions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euphorbia schimperiana is a distinct herbaceous plant that functions as a self-supporting species in its natural habitat. This herb typically maintains a compact stature, with most specimens reaching a maximum height of approximately 1.22 meters. While many individuals grow to a minimum height of about 0.61 meters, some instances can reach slightly larger proportions. Interestingly, certain documented variations suggest heights can reach or exceed 1.5 meters under specific conditions. Overall, its growth form remains consistent with the characteristics of a sturdy, upright herb.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Euphorbia schimperiana is a medicinal plant traditionally utilized to treat various ailments, including cough, tuberculosis, and skin infections. Recent scientific investigations have focused on the secondary metabolites found within its roots to validate these traditional uses. Through the use of silica gel column chromatographic separation, researchers have been able to isolate specific bioactive compounds from the plant. These isolated compounds were evaluated via the broth dilution method and demonstrated significant antimicrobial activity against pathogens such as Staphylococcus aureus, Escherichia coli, and Candida albicans. These findings suggest that the chemical constituents of the plant hold great promise as potential drug candidates for treating infectious diseases.
Compounds
Conditions
Euphorbia schimperiana exhibits potent antiproliferative activity against several human cancer cell lines. Specifically, the plant extracts demonstrate the ability to treat A427 lung cancer cells. This medicinal plant also shows effective cytotoxic action against DAN-G pancreatic cancer cells. Furthermore, its extracts are capable of treating A2780 ovarian cancer cell lines. Finally, Euphorbia schimperiana provides treatment against KYSE-70 squamous cell carcinoma and HL-60 acute myeloid leukemia cells.
Preparations
Euphorbia schimperiana is prepared as 80% methanol extracts to evaluate its medicinal potential. This specific extraction method was utilized to screen the plant for cytotoxic activities against various human cancer cell lines. The resulting extracts demonstrated potent antiproliferative activity against multiple lines, including A427, RT-4, MCF-7, and SiSo. Furthermore, the 80% methanol preparation showed significant efficacy against LCLC-103H, DAN-G, and several other cancer types. These findings highlight the importance of using 80% methanol extracts to identify the active compounds within Euphorbia schimperiana.
Parts used
Euphorbia schimperiana is a medicinal plant traditionally utilized in Ethiopian folk medicine to treat various ailments such as cough, asthma, and skin infections. Recent scientific investigations have focused on the chemical composition of its roots to uncover potential therapeutic benefits. Through silica gel column chromatographic separation, researchers isolated several key compounds from the dichloromethane root extract. These bioactive molecules were further evaluated using molecular docking and DFT analysis to predict their antimicrobial and anticancer properties. Ultimately, the study of these root-derived metabolites suggests that the plant holds significant promise as a source for new drug candidates.